Title
Category
Credits
Event date
Cost
Determinants of Hepatitis C Virus Prevalence in People With Serious Mental Illness: A Systematic Review and Meta-Analysis
  • Hepatitis
  • Medical Conditions
  • Neuropsychiatric Disorders
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Increased screening for hepatitis C virus among people with serious mental illness is key to achieving global eradication of the virus.
An Individualized Approach to PAH Therapy Based on Clinical Data, Goal-Directed Therapy, and Risk Stratification 
  • Cardiology
  • Comorbidity
  • Education
  • Integrated Care
  • Medical Conditions
  • Pulmonary Disease
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Pulmonary arterial hypertension requires risk stratification to develop goal-directed treatment plans, including combination therapy targeting multiple pathways.
Translating Clinical Trial Data into Real-World Practice: Examining CKD Screening and Three Patient Case Profiles
  • Renal Disease
  • Adherence
  • Cardiology
  • Comorbidity
  • Diagnostic Tools
  • Education
  • Medical Conditions
  • Primary Care
  • Side Effects
  • Weight
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases.